Adriamycin-Induced Nephropathy is Robust in N and Modest in J Substrain of C57BL/6

Claire Bryant, Rachel E. Cianciolo, Rajgopal Govindarajan, Shipra AgrawalFrontiers in Cell and Developmental Biology 2022 · DOI

TL;DR

This study clarifies the differential susceptibility of two common C57BL/6 mouse substrains (N and J) to Adriamycin (ADR)-induced nephropathy, a key model for human kidney disease. The findings establish that the N substrain develops robust nephropathy, while the J substrain exhibits a more modest response, providing a crucial resource for researchers using genetically modified C57BL/6 mice for kidney disease studies.

What Problem Does This Paper Address?

Focal segmental glomerulosclerosis (FSGS) is a major cause of chronic kidney disease, and the Adriamycin (ADR)-induced nephropathy model in mice is a leading tool for studying its mechanisms and potential therapies. However, a significant hurdle has been the historical classification of the widely used C57BL/6 mouse strain as resistant to ADR. This resistance, coupled with conflicting reports on ADR-induced nephropathy in C57BL/6 mice, has stemmed from a lack of understanding regarding substrain differences (specifically the N and J substrains) and variability in experimental protocols (ADR dosage, timing, and frequency). This ambiguity has hampered the use of C57BL/6 mice, which are prevalent in genetic engineering, for FSGS research. This paper aims to systematically elucidate these substrain differences to establish a reproducible ADR-induced nephropathy model in C57BL/6 mice.

Methods

The researchers employed a standardized protocol to induce nephropathy in male C57BL/6J (J) and C57BL/6N (N) mice. Two intravenous injections of ADR (15 mg/kg body weight) were administered 10 days apart. Urine and serum were collected bi-weekly for six weeks to measure albuminuria and serum creatinine. Body weight was also monitored throughout the study. Histological analysis of kidney tissue was performed using Periodic Acid-Schiff (PAS) staining to assess glomerular and tubular damage, including segmental sclerosis, podocyte hypertrophy, tubular dilation, and protein casts. Immunofluorescence staining was used to evaluate the expression of key podocyte markers: synaptopodin, WT1, nephrin, and podocin. Additionally, quantitative real-time PCR (qRT-PCR) was used to assess Nphs2 (podocin) gene expression.

Datasets

Not discussed in the paper. The study utilized live animal models and their biological samples (urine, serum, kidney tissue).

Key Insights and Ideas

  • Substrain Specificity is Crucial: The study definitively shows that not all C57BL/6 mice are created equal when it comes to ADR-induced nephropathy. The N substrain is significantly more susceptible than the J substrain.
  • A Reproducible Model is Now Available: By standardizing the ADR dosage and frequency, the authors have created a reliable method to induce FSGS-like pathology in a commonly used mouse strain, overcoming previous inconsistencies.
  • Bridging the Gap for Genetic Studies: This work is vital for researchers using genetically modified C57BL/6 mice. It provides a clear understanding of how to induce nephropathy in these strains, potentially saving considerable effort in backcrossing to more susceptible strains.
  • Podocyte Injury is Key: The observed reduction in critical podocyte markers (synaptopodin, nephrin, WT1, podocin) directly correlates with the degree of proteinuria and histological damage, reinforcing the role of podocyte dysfunction in ADR-induced FSGS.

Key Results

  • Proteinuria: The N substrain exhibited robust and significantly higher albuminuria (9.5-fold increase from baseline at week 6) compared to the J substrain (3-fold increase from baseline at week 6). Albuminuria was consistently higher in N vs. J substrains from week 2 to week 6.
  • Serum Creatinine: Serum creatinine levels were significantly elevated in the N substrain (~5-fold increase at week 6) but remained unchanged in the J substrain.
  • Body Weight: Both substrains experienced weight loss, with the N substrain showing a greater percentage decrease in body weight by week 6.
  • Histology: Histological analysis revealed more severe glomerular and tubular damage in the N substrain, including increased segmental sclerosis, podocyte hypertrophy, tubular dilation, and protein casts, compared to the J substrain.
  • Podocyte Markers: Expression of synaptopodin, nephrin, podocin, and WT1 was downregulated in ADR-injured kidneys, with more pronounced reductions observed in the N substrain. Nphs2 (podocin) gene expression was significantly reduced in the N substrain after ADR treatment.
  • Mortality: Importantly, no mortality was observed in either substrain under the experimental conditions, even with palliative care measures.

Limitations and Future Work

  • Sex Differences: The study exclusively used male mice. The authors acknowledge that female mice are known to be more resistant to ADR-induced injury, particularly in the C57BL/6J strain, and suggest that future studies should investigate sex-dependent outcomes.
  • Further Protocol Optimization: While the study provides a robust protocol, the authors hint that even the J substrain could potentially be made more proteinuric with modified protocols, suggesting room for further refinement.
  • Broader Genetic Applications: The authors envision their findings enabling more efficient genetic studies by guiding the selection of the appropriate C57BL/6 substrain for specific research questions, potentially reducing the need for extensive backcrossing. They also suggest the J substrain's modest response could be a valuable model for studying gene interactions or exacerbation of injury.

Summary updated

Abstract

Adriamycin (ADR)-induced nephropathy remains the leading model to study human primary focal segmental glomerulosclerosis (FSGS), a common pathway for podocyte damage and glomerular loss of function that leads to chronic kidney disease. However, the use of this model for reverse genetics is limited by historical categorization of C57BL/6 mice as an ADR-resistant strain, which is also the most common genetically modified strain. Additionally, conflicting reports exist utilizing C57BL/6 for ADR-nephrosis due to lack of understanding of substrain differences (J/N) and variability in ADR dosage, timing, and frequency to induce damage. We have undertaken a systematic approach to elucidate the specifics of ADR-nephrosis in C57BL/6 N and J substrains. We induced nephropathy with 2 doses of ADR, and measured albuminuria for 6 weeks and performed histological evaluations. Our findings revealed induction of robust and modest proteinuria in N and J substrains, respectively. The serum creatinine levels were elevated in N, but not J substrain. Both the substrains showed reduction in body weight with N greater than J, although mortality remained at 0% in both substrains. Histological analysis showed worse renal lesions in the N than the J substrain. Podocyte markers synaptopodin, nephrin, podocin, and WT1 were reduced to a greater extent in the N than the J substrain. In summary, we provide the nephrology community with a reproducible mouse model for FSGS, in a strain otherwise assumed to be ADR-resistant and highlight the differences between J and N substrains. This enables future studies, especially concerning genetically manipulated animal models in C57BL/6.
BibTeX
@inproceedings{bryant2022adriamycin,
  author = {Claire Bryant and Rachel E. Cianciolo and Rajgopal Govindarajan and Shipra Agrawal},
  title = {{Adriamycin-Induced Nephropathy is Robust in N and Modest in J Substrain of C57BL/6}},
  booktitle = {Frontiers in Cell and Developmental Biology},
  year = {2022},
  doi = {10.3389/fcell.2022.924751},
}
Figure